Literature DB >> 23872278

Generation and utility of genetically humanized mouse models.

Nico Scheer1, Mike Snaith, C Roland Wolf, Jost Seibler.   

Abstract

Identifying in vivo models that are naturally predictive for particular areas of study in humans can be challenging due to the divergence that has occurred during speciation. One solution to this challenge that is gaining increasing traction is the use of genetic engineering to introduce human genes into mice to generate superior models for predicting human responses. This review describes the state-of-the-art for generating such models, provides an overview of the types of genetically humanized mouse models described to date and their applications in basic research, drug discovery and development and to understand clinical drug toxicity. We discuss limitations and explore promising future directions for the use of genetically humanized mice to further improve translational research.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23872278     DOI: 10.1016/j.drudis.2013.07.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

Review 1.  Humanized Mice in Dermatology Research.

Authors:  Russell L Griffin; Thomas S Kupper; Sherrie J Divito
Journal:  J Invest Dermatol       Date:  2015-12       Impact factor: 8.551

Review 2.  Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Authors:  Frank J Gonzalez; Zhong-Ze Fang; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-04-02       Impact factor: 4.481

Review 3.  Preclinical mouse cancer models: a maze of opportunities and challenges.

Authors:  Chi-Ping Day; Glenn Merlino; Terry Van Dyke
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

Review 4.  Design and engineering of deimmunized biotherapeutics.

Authors:  Karl E Griswold; Chris Bailey-Kellogg
Journal:  Curr Opin Struct Biol       Date:  2016-06-17       Impact factor: 6.809

5.  Generation of a functional humanized Delta-like ligand 4 transgenic mouse model.

Authors:  John Wiseman; Pernilla Gregersson; Johan Johansson; Kerstin Magnell; Fernanda Pilataxi; Chris Morehouse; Philip Brohawn; Nicholas Holoweckyj; Patrick Strout; Song Cho
Journal:  Transgenic Res       Date:  2017-08-17       Impact factor: 2.788

Review 6.  Porcine models of digestive disease: the future of large animal translational research.

Authors:  Liara M Gonzalez; Adam J Moeser; Anthony T Blikslager
Journal:  Transl Res       Date:  2015-01-13       Impact factor: 7.012

7.  Efficient gene-targeting in rat embryonic stem cells by CRISPR/Cas and generation of human kynurenine aminotransferase II (KAT II) knock-in rat.

Authors:  Satoshi Yamamoto; Yuki Ooshima; Mitsugu Nakata; Takashi Yano; Naoya Nishimura; Ryuuichi Nishigaki; Yoshinori Satomi; Hirokazu Matsumoto; Yoshio Matsumoto; Michiyasu Takeyama
Journal:  Transgenic Res       Date:  2015-10-10       Impact factor: 2.788

Review 8.  The safety evaluation of food flavouring substances: the role of metabolic studies.

Authors:  Robert L Smith; Samuel M Cohen; Shoji Fukushima; Nigel J Gooderham; Stephen S Hecht; F Peter Guengerich; Ivonne M C M Rietjens; Maria Bastaki; Christie L Harman; Margaret M McGowen; Sean V Taylor
Journal:  Toxicol Res (Camb)       Date:  2018-03-28       Impact factor: 3.524

9.  Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/⁺WAPCre mouse model.

Authors:  Bas ter Braak; Christine Siezen; Ewoud N Speksnijder; Esmee Koedoot; Harry van Steeg; Daniela C F Salvatori; Bob van de Water; Jan Willem van der Laan
Journal:  Breast Cancer Res       Date:  2015-02-18       Impact factor: 6.466

Review 10.  Humanising the mouse genome piece by piece.

Authors:  Fei Zhu; Remya R Nair; Elizabeth M C Fisher; Thomas J Cunningham
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.